Trial site
Medical Center New Polyclinic Gabrovo Ltd.
- 10running trials
- 6closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Heart failure4 trials
- High blood pressure4 trials
- Obesity3 trials
- Type 2 diabetes3 trials
- Chronic kidney disease2 trials
- Stroke2 trials
- Atrial fibrillation1 trial
- Peripheral artery disease1 trial
- Phase
- Phase 313 trials
- Phase 23 trials
- Status
- Completed6 trials
- Recruiting6 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Boehringer Ingelheim2 trials
- Mineralys Therapeutics Inc.2 trials
- Novo Nordisk A/S2 trials
- Pfizer2 trials
- Regeneron Pharmaceuticals2 trials
- and 6 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Active, not recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease2 recruiting
- High blood pressure2 recruiting
- Stroke2 recruiting
- Type 2 diabetes2 recruiting
- Atrial fibrillation1 recruiting
- Heart failure1 recruiting
- Obesity1 recruiting
- Peripheral artery disease1 recruiting
Closed trials
Completed
Completed
Completed
A proof of concept and dose-finding study of XXB750 in patients with heart failure
Completed
Completed
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension
Active, not recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026